Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015

Details for Mechanism ID: 13548
Country/Region: Kenya
Year: 2011
Main Partner: Management Sciences for Health
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $3,500,000


Goals and Objectives

Under COP 2010, SPS approach to TA will involve deliberate and participatory inclusion of GOK counterparts to ensure buy in and sustainability. SPS capacity building efforts will also target strengthening of local partners such as Universities, Kenya Medical Training College, Professional and accrediting bodies. MSH/SPS will provide technical assistance and support to GOK counterparts and stakeholders under the following broad technical objectives.

Objective 1: To support access to medicines by providing technical leadership and assistance in pharmaceutical management system strengthening.

One of the key goals of GOK and USG is to improve access and use of high quality and efficacious medicines for prevention, care & treatment. To achieve this, constant and uninterrupted supply of medicines to sites is crucial. SPS Technical Assistance will aim to improve supply chain efficiency, rational use, commodity quality, system capacity, information management and improved supply chain and logistics monitoring & evaluation. MSH/SPS will provide support to National commodity security working groups. MSH/SPS will provide technical assistance to key organizations in the area of commodity quantification & forecasting, procurement planning, distribution resource planning, human capacity development, commodity supply chain operations management strengthening, Pharmaceutical/MIS and M&E.

Objective 2: To improve the capacity of GOK and Non-GOK institutions for pharmaceutical management.

To address existing HR and institutional pharmaceutical management issues, MSH/SPS will provide targeted training at national and regional levels. These trainings will be undertaken using a variety of approaches including pre-service, in-service, OJT, mentorship, apprenticeships and facility based performance improvement approaches such as MTP. Institutionally, MSH/SPS will continue to provide manual and electronic commodity management tools, SOPs, user handbooks, flow charts and job aids. SPS will continue to support GOK with commodity decentralization and task shifting initiatives in line with Health Sector Strategic and Reform Plans. SPS will continue to work with institutions and systems that are charged with the role of ensuring the quality of pharmaceutical services.

Objective 3: To strengthen the pharmaceutical and logistics information management systems (P/LMIS) in support of priority GOK Health programs

USG and other donor-supported parallel health programs have continued to rely on the Logistics Management Unit (LMU) as a source of access and use commodity management data. In particular, LMU database provides routine data for decision making in support of priority prevention and treatment programs such as HIV/AIDS, TB/ Leprosy, Malaria, Reproductive health and laboratory commodities.

Under COP 2010, MSH/SPS will continue to support LMU routine operations including the maintenance the database that tracks nationwide usage of priority commodities. Information maintained by the LMU will continue to inform KEMSA and user departments in commodity re-supply decisions and commodity security issues.

Objective 4: To provide technical support for commodity management activities in support of TB/HIV activities undertaken by the Division of Leprosy, TB and Lung Diseases (DLTLD).

The national TB & Leprosy program's main activities focus on DOTS expansion, active case detection, and more recently TB/HIV collaboration and services. MSH/SPS will continue to support the DLTLD centrally by providing technical assistance to MOH/DLTLD activities aimed at strengthening TB Commodity Supply chain in order to improve access to and use of quality pharmaceutical products in support of TB management and TB/HIV services. MSH/SPS will also support the peripheral TB/HIV activities by strengthening the institutional and human resource capacity for TB/HIV commodity management practices. This will include but not limited to trainings, support to development and implementation of various tools and job aids, new approaches for support supervision, provision of tools for reporting on TB commodity use among others.

Objective 5: To increase the capacity of GOK to improve access to and provision of quality medical laboratory services.

Quality laboratory services for diagnosis and monitoring is an important determinant for success of a national HIV/AIDS program. In many instances, the laboratory has been found to be the rate limiting factor to treatment and prevention programs.

MSH/SPS will continue to work with GOK and USG partners to improve laboratory commodity management with particular emphasis of the revision and implementation of a National Laboratory Policy and Strategic Plan.

Linkages to Partnership Framework

GOK health commodity projection, procurement, warehousing, and distribution systems each increased from16 mutually-agreed baselines and in a manner that builds on Millennium Challenge Corporation Threshold Program

Funding for Care: Adult Care and Support (HBHC): $200,000


Funding for Treatment: Adult Treatment (HTXS): $300,000


Funding for Laboratory Infrastructure (HLAB): $1,000,000


Funding for Treatment: ARV Drugs (HTXD): $2,000,000


Key Issues Identified in Mechanism
End-of-Program Evaluation